Latest news & insights
Dr Karen Mullen appointed as Chief Medical Officer
Boyds is delighted to announce the appointment of experienced pharmaceutical physician Dr Karen Mullen FFPM as Chief Medical Offer (CMO) and Vice President of Clinical
Strong growth in the US boosts revenue for Boyds
Boyds is delighted to report another strong year of growth, with an increase in excess of 20 percent year-on-year in annual revenue in the wake
Boyds boosts specialist clinical expertise with appointment of Dr Harriet Gray Stephens
Boyds is delighted to announce the appointment of Pharmaceutical Physician, Dr Harriet Gray Stephens, to the Clinical and Medical Affairs group to further strengthen the
Katy Rudnick awarded Aiko Maruya award for Excellence in Regulatory Science
Boyds congratulates Katy Rudnick, Vice President and Head of US Regulatory Affairs, on being awarded the Aiko Maruya Award from the USC School of Pharmacy.
Pippa Bjaaland graduates with MSc in Cancer and Clinical Oncology with distinction.
Boyds is delighted to congratulate Pippa Bjaaland, Senior CRA at Boyds, on graduating with an MSc in Cancer and Clinical Oncology from Queen Mary University
Eamonn McGowran: Medical Devices Regulatory Specialist joins Boyds
Boyds is delighted to announce the appointment of regulatory expert in the pharma, biotech and medical devices sectors, Eamonn McGowran, as Associate Director. Based at
Boyds goes for growth with key appointment of Dr Neil Fish
Boyds is delighted to announce the appointment of business development expert Dr Neil Fish to support the company as it embarks on the next stage
Boyds expands product development team
Boyds has added two experienced product development experts to its team, amid growing demand for specialist Product Development services from clients in the UK, Europe and the
